Quinazoline Synthesis via Phase-Transfer Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing quinazoline compounds for treating HCMV infections are inefficient, requiring multiple steps and resulting in low yields, which complicates the production of effective inhibitors for the virus.
Innovation Solution
A process involving the use of a phase-transfer catalyst and a base in a mixture of water and organic solvent to synthesize Substituted Quinazoline Compounds of Formula (I), which includes fewer steps and provides a high degree of stereoselectivity and improved yield, specifically targeting HCMV inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current synthesis methods are used, then quinazoline compounds can be produced, but the process requires multiple steps and results in low yields
Solution Approach 1:
The patent combines multiple synthesis steps into a single reaction step by using a phase-transfer catalyst to facilitate the interaction between reagents in different phases. This merging of steps directly reduces the total number of operations required while maintaining or improving the final yield of the quinazoline compound.
Solution Approach 2:
The phase-transfer catalyst acts as an intermediary substance that enables the reaction to proceed efficiently by transferring reactants between aqueous and organic phases. This mediator allows the multi-step synthesis to be accomplished in fewer steps with higher yield, as the catalyst facilitates the key transformation without requiring isolation of intermediate products.
2Ease of manufacture
If current synthesis methods are used, then quinazoline compounds can be produced, but the process is inefficient and complicates production
Solution Approach 1:
By merging multiple synthesis operations into a single phase-transfer catalyzed reaction, the patent simultaneously improves ease of manufacture (fewer isolation and purification steps) and maintains high productivity (improved yield). This consolidation makes the production process simpler while remaining efficient.
Solution Approach 2:
The patent changes the reaction parameters by introducing a phase-transfer catalyst system that operates under milder conditions and allows for better control of the reaction. This parameter change simplifies the manufacturing process by eliminating the need for complex multi-step procedures while maintaining or improving synthesis efficiency.
3Manufacturing precision
If current synthesis methods are used, then quinazoline compounds can be produced, but stereoselectivity is not optimized
Solution Approach 1:
The phase-transfer catalyst serves as a chiral intermediary that transfers optical information from the chiral auxiliary to the product during the reaction. This mediator enables high stereoselectivity in a single step, avoiding the need for complex multi-step processes that would otherwise be required to achieve the same level of stereocontrol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process efficiently produces quinazoline compounds with high stereoselectivity and yield, effectively inhibiting HCMV replication and providing a more practical route for therapeutic applications.
Implementation Method 1
contacting a compound of formula (viii) or a salt thereof, with a phase-transfer catalyst and a base, in a mixture of water and organic solvent A
Data Source
AI summary
The present invention is directed to a process for making Substituted Quinazoline Compounds of formula (I): which are useful for the treatment and prophylaxis of HCMV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).